Beyond Air (NASDAQ:XAIR) Posts Earnings Results, Beats Estimates By $0.09 EPS

Beyond Air (NASDAQ:XAIR) issued its quarterly earnings data on Monday. The company reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.09, Zacks reports. Beyond Air had a negative return on equity of 227.29% and a negative net margin of 2,369.17%. During the same period in the prior year, the business posted ($0.50) EPS.

Beyond Air Stock Up 5.4 %

XAIR stock opened at $0.44 on Tuesday. Beyond Air has a fifty-two week low of $0.30 and a fifty-two week high of $2.17. The stock has a market capitalization of $33.28 million, a P/E ratio of -0.31 and a beta of -0.15. The company has a debt-to-equity ratio of 0.37, a current ratio of 5.76 and a quick ratio of 5.38. The business has a 50-day moving average of $0.42 and a 200-day moving average of $0.44.

About Beyond Air

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.